Reports
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States
Americas
Future Market Insights, Inc.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States
MEA
Future Market Insights
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom
Asia Pacific
Future Market Insights
IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India
The global Burns Treatment Market is expected to garner a market value of US$ 1.2 Billion in 2023 and is expected to accumulate a market value of US$ 2.59 Billion by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Burns Treatment registered a CAGR of 5% in the historical period 2018 to 2022.
The burn treatment market is a segment of the healthcare industry that deals with the treatment of burn injuries. Burn injuries can range from minor to severe and can have a significant impact on a person's quality of life. The burn treatment market offers a range of products and services for the management and treatment of burn injuries, including wound dressings, topical agents, pain management products, and reconstructive surgery products.
Report Attribute | Details |
---|---|
Expected Market Value (2023) | US$ 1.2 Billion |
Anticipated Forecast Value (2033) | US$ 2.59 Billion |
Projected Growth Rate (2023 to 2033) | 8% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to market research and competitive intelligence provider Future Market Insights- the market for Burns Treatment reflected a value of 5% during the historical period, 2018 to 2022.
A series of international level collaborations involving healthcare stakeholders across various institutional settings are fueling further clinical trials and research studies dedicated to discovering effective ways for Burns Treatment.
According to the National Center for Biotechnology Information, Approximately 486,000 patients require treatment for burns, and 40,000 require hospitalization within the United States each year. Nationally, 70% of patients who are burned receive burns that comprise less than 10% total body surface area (%TBSA), and 88% of all patients receive a less than 20% TBSA burn
In its new study, ESOMAR-certified market research and consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for Burns Treatment. In the years to come, increasing focus by government organizations and private agencies like WHO and pharmaceutical companies to create awareness of burn treatments is fuelling the market growth. Thus, the market for Burns Treatment is expected to register a CAGR of 8% in the forecast period 2023 to 2033.
Increased Prevalence of the Burn Injuries to Push the Market Growth
WHO reports that burns are a global public health problem, accounting for an estimated 180,000 deaths annually. The majority of these occur in low- and middle-income countries and almost two thirds occur in the WHO African and South-East Asia regions. In many high-income countries, burn death rates have been decreasing, and the rate of child deaths from burns is currently over 7 times higher in low- and middle-income countries than in high-income countries.
The rise in burn cases has fueled the need for advanced dressings like alginate, hydrogel, foam, hydrocolloid, collagen, etc. and biologics like skin grafts and traditional burn treatment products. With a variety of such products available, awareness of burn treatment among patients and healthcare professionals like surgeons, doctors, and nurses is growing.
For instance, in June 2022, The USA Food and Drug Administration approved StrataGraft for the treatment of deep partial thickness burns in adult patients. These burns are caused by direct contact with heat sources such as fire, hot surfaces, scalding water, or steam. StrataGraft offers healthcare professionals a new way to treat burn wounds and improve patient recovery by helping them return to their highest level of functionality and quality of life.
The treatment involves applying StrataGraft, made from human skin cells grown together to form a bi-layered construct, onto the burn. This can help reduce the need for skin grafting, where healthy skin is taken from the patient's body to cover the burn wound, leaving a new wound where the skin was removed. Over time, the patient's skin cells should grow to replace the lost skin cells, promoting healing.
Expensive Cost of Treatment to restrict Market Growth
The market is projected to get significantly affected by the challenging factors such as limited availability and high cost of advanced burn treatment products, lack of trained healthcare professionals in burn treatment, limited access to quality burn care facilities in developing countries, stringent government regulations for approval of burn treatment products, insufficient reimbursement for burn treatment procedures, competition from alternative treatments such as skin grafting and tissue engineering, risk of infections and other complications during burn wound treatment and so on.
Furthermore, lack of health remuneration policies, rise in cost, and side effects associated with certain treatments is expected to hinder the market growth.
Improvement in healthcare spending propelling growth of Burns Treatment in Asia Pacific
The Asia Pacific is expected to exhibit the significant growth rate of all regions over the forecast period, with a CAGR of 5% during the forecast period. The growth is owed to increased awareness, significant increases in healthcare spending, and a rising frequency of Burns Treatment Market in the region. Asia Pacific is an emerging market due to the increase in point of care approach to health & care. Increasing number of hospitals in India and China makes a promising market for the market worldwide.
India is expected to dominate the burn treatment market due to its large population and easy access to burn treatment products. The high population density increases the risk of cross-infection among patients, which is why top hospitals in India have equipped themselves with 30 isolated cubicles in ICUs and 10 private isolation beds to reduce the spread of infection. These factors make India a lucrative market for burn treatment products.
Technological Advancements Shaping Landscape for Burns Treatment in North America
North America is anticipated to acquire a market share of about 25% in the forecast period. This growth is attributable to the rising prevalence of the condition in the region. According to a 2018 report by the American Burn Association, over 300 children are treated in emergency rooms in the United States each day, with roughly two children dying from burn injuries. In the USA, children aged 16 and under account for roughly 26% of all burn center admissions. In addition, the National Center for Biotechnology Information (NCBI) estimates that 486,000 individuals are injured by fire each year. Thereby, the demand for burn treatment is anticipated to be in high demand as a result of a high rate of burns.
Furthermore, government initiatives and increase in the number of research partnerships are boosting the market growth across North America. The United States of America leads the regional market owing to the rising awareness about the condition and increasing number of populations with burn injuries is pushing the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Wound care dressings as an effective treatment to drive the market
According to the FMI analysis, alginate dressings are expected to grow with a CAGR of 7%. Alginate is a key component in various wound dressings such as hydrogels, films, wafers, foams, nanofibers, and topical preparations. The ability of alginate dressings to absorb excess wound fluid, create a moist environment, and reduce the risk of bacterial infections has driven the sales of these products. Alginate, a biopolymer, is widely used in biomedical applications due to its biocompatibility and non-toxicity, with wound healing being a particularly appealing use.
Second degree burns to take the lead and drive market growth
The second-degree burn segment is projected to grow at the fastest pace over the forecast period. Chronic wounds, including partial-thickness and full-thickness burns, take longer to heal and can cover more than 15% of the body. According to the FDA, around 40,000 people are hospitalized annually due to partial burns. The demand for biologics, like skin grafts and advanced dressings, is increasing to treat partial burns, driving the growth of the segment. Furthermore, favorable reimbursement policies in developed countries for second degree burn patients are expected to drive the segment's growth.
Key players in the Burns Treatment Market are Smith & Nephew, ConvaTec Group, B. Braun Melsungen AG, Molnlycke Health Care, Integra LifeSciences, Coloplast A/S, Paul Hartmann AG, 3M, Acelity L.P. Inc., and Medtronic among other global players.
Report Attribute | Details |
---|---|
Market Value in 2023 | US$ 1.2 Billion |
Market Value in 2033 | US$ 2.59 Billion |
Growth Rate | CAGR of 8% from 2023 to 2033 |
Base Year for Estimation | 2022 |
Historical Data | 2018 to 2022 |
Forecast Period | 2023 to 2033 |
Quantitative Units | Revenue in USD Million and CAGR from 2023 to 2033 |
Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
Segments Covered |
|
Regions Covered |
|
Key Countries Profiled |
|
Key Companies Profiled |
|
Customization | Available Upon Request |
The market’s net worth is expected to be US$ 1.2 billion in 2023.
The projected market value of burns treatment is US$ 2.59 billion by 2033.
The Asia Pacific is expected to expand at a CAGR of 5% over the forecast period.
Wound care dressings are preferred for treating burns.
Second degree burns account for considerable market share.
1. Executive Summary | Burns Treatment Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Treatment Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Type, 2023 to 2033 5.3.1. Wound Care Dressings 5.3.1.1. Antimicrobial Dressings 5.3.1.2. Hydrocolloid Dressings 5.3.1.3. Hydrogel Dressings 5.3.1.4. Film Dressings 5.3.1.5. Foam Dressings 5.3.1.6. Alginate Dressings 5.3.2. Wound Care Therapy 5.3.2.1. Thermal Burn Therapy 5.3.2.2. Negative Pressure Wound Therapy 5.3.2.3. Ultrasound Therapy 5.3.2.4. Hyperbaric Oxygen Therapy 5.3.3. Medications 5.3.3.1. Burn Creams & Ointments 5.3.3.2. Anti-infective Drugs 5.3.3.3. Painkillers & Anti-anxiety Medications 5.3.3.4. IV-Fluids & Therapeutic Peptide Nutrition 5.3.4. Surgeries 5.4. Y-o-Y Growth Trend Analysis By Treatment Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Treatment Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Degree of Burn 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Degree of Burn, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Degree of Burn, 2023 to 2033 6.3.1. First-degree Burns 6.3.2. Second-degree Burns 6.3.3. Third-degree Burns 6.4. Y-o-Y Growth Trend Analysis By Degree of Burn, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Degree of Burn, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Europe 7.3.4. South Asia 7.3.5. East Asia 7.3.6. Oceania 7.3.7. MEA 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. USA 8.2.1.2. Canada 8.2.2. By Treatment Type 8.2.3. By Degree of Burn 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Treatment Type 8.3.3. By Degree of Burn 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Treatment Type 9.2.3. By Degree of Burn 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Treatment Type 9.3.3. By Degree of Burn 9.4. Key Takeaways 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. United Kingdom 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Europe 10.2.2. By Treatment Type 10.2.3. By Degree of Burn 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Treatment Type 10.3.3. By Degree of Burn 10.4. Key Takeaways 11. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. India 11.2.1.2. Malaysia 11.2.1.3. Singapore 11.2.1.4. Thailand 11.2.1.5. Rest of South Asia 11.2.2. By Treatment Type 11.2.3. By Degree of Burn 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Treatment Type 11.3.3. By Degree of Burn 11.4. Key Takeaways 12. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Treatment Type 12.2.3. By Degree of Burn 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Treatment Type 12.3.3. By Degree of Burn 12.4. Key Takeaways 13. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. Australia 13.2.1.2. New Zealand 13.2.2. By Treatment Type 13.2.3. By Degree of Burn 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Treatment Type 13.3.3. By Degree of Burn 13.4. Key Takeaways 14. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Treatment Type 14.2.3. By Degree of Burn 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Treatment Type 14.3.3. By Degree of Burn 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. USA 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Treatment Type 15.1.2.2. By Degree of Burn 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Treatment Type 15.2.2.2. By Degree of Burn 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Treatment Type 15.3.2.2. By Degree of Burn 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Treatment Type 15.4.2.2. By Degree of Burn 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Treatment Type 15.5.2.2. By Degree of Burn 15.6. United Kingdom 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Treatment Type 15.6.2.2. By Degree of Burn 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Treatment Type 15.7.2.2. By Degree of Burn 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Treatment Type 15.8.2.2. By Degree of Burn 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Treatment Type 15.9.2.2. By Degree of Burn 15.10. India 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Treatment Type 15.10.2.2. By Degree of Burn 15.11. Malaysia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Treatment Type 15.11.2.2. By Degree of Burn 15.12. Singapore 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Treatment Type 15.12.2.2. By Degree of Burn 15.13. Thailand 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Treatment Type 15.13.2.2. By Degree of Burn 15.14. China 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Treatment Type 15.14.2.2. By Degree of Burn 15.15. Japan 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Treatment Type 15.15.2.2. By Degree of Burn 15.16. South Korea 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Treatment Type 15.16.2.2. By Degree of Burn 15.17. Australia 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Treatment Type 15.17.2.2. By Degree of Burn 15.18. New Zealand 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Treatment Type 15.18.2.2. By Degree of Burn 15.19. GCC Countries 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Treatment Type 15.19.2.2. By Degree of Burn 15.20. South Africa 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Treatment Type 15.20.2.2. By Degree of Burn 15.21. Israel 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Treatment Type 15.21.2.2. By Degree of Burn 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Treatment Type 16.3.3. By Degree of Burn 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. MediWound Germany GmbH 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Kaken Pharmaceutical Co., Ltd. 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Kerecis 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Mallinckrodt Pharmaceuticals 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. Avita Medical 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Vericel Corporation 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. KeraNetics 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Integra LifeSciences Corporation 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. PolyNovo 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Medline Industries 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Anika Therapeutics, Inc. 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. ACell, Inc. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. Amryt Pharma 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.14. CUTISS AG 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 17.1.15. Skingenix 17.1.15.1. Overview 17.1.15.2. Product Portfolio 17.1.15.3. Profitability by Market Segments 17.1.15.4. Sales Footprint 17.1.15.5. Strategy Overview 17.1.15.5.1. Marketing Strategy 17.1.16. RenovaCare 17.1.16.1. Overview 17.1.16.2. Product Portfolio 17.1.16.3. Profitability by Market Segments 17.1.16.4. Sales Footprint 17.1.16.5. Strategy Overview 17.1.16.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Degree of Burn, 2018 to 2033 Table 4: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Degree of Burn, 2018 to 2033 Table 7: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 8: Latin America Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Degree of Burn, 2018 to 2033 Table 10: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 11: Europe Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 12: Europe Market Value (US$ Million) Forecast by Degree of Burn, 2018 to 2033 Table 13: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: South Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 15: South Asia Market Value (US$ Million) Forecast by Degree of Burn, 2018 to 2033 Table 16: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 17: East Asia Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 18: East Asia Market Value (US$ Million) Forecast by Degree of Burn, 2018 to 2033 Table 19: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 20: Oceania Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 21: Oceania Market Value (US$ Million) Forecast by Degree of Burn, 2018 to 2033 Table 22: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 23: MEA Market Value (US$ Million) Forecast by Treatment Type, 2018 to 2033 Table 24: MEA Market Value (US$ Million) Forecast by Degree of Burn, 2018 to 2033
Figure 1: Global Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Degree of Burn, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 4: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 7: Global Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 8: Global Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 9: Global Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 10: Global Market Value (US$ Million) Analysis by Degree of Burn, 2018 to 2033 Figure 11: Global Market Value Share (%) and BPS Analysis by Degree of Burn, 2023 to 2033 Figure 12: Global Market Y-o-Y Growth (%) Projections by Degree of Burn, 2023 to 2033 Figure 13: Global Market Attractiveness by Treatment Type, 2023 to 2033 Figure 14: Global Market Attractiveness by Degree of Burn, 2023 to 2033 Figure 15: Global Market Attractiveness by Region, 2023 to 2033 Figure 16: North America Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 17: North America Market Value (US$ Million) by Degree of Burn, 2023 to 2033 Figure 18: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 19: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 22: North America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 23: North America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 24: North America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Degree of Burn, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Degree of Burn, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Degree of Burn, 2023 to 2033 Figure 28: North America Market Attractiveness by Treatment Type, 2023 to 2033 Figure 29: North America Market Attractiveness by Degree of Burn, 2023 to 2033 Figure 30: North America Market Attractiveness by Country, 2023 to 2033 Figure 31: Latin America Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 32: Latin America Market Value (US$ Million) by Degree of Burn, 2023 to 2033 Figure 33: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 34: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 37: Latin America Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 38: Latin America Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 40: Latin America Market Value (US$ Million) Analysis by Degree of Burn, 2018 to 2033 Figure 41: Latin America Market Value Share (%) and BPS Analysis by Degree of Burn, 2023 to 2033 Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Degree of Burn, 2023 to 2033 Figure 43: Latin America Market Attractiveness by Treatment Type, 2023 to 2033 Figure 44: Latin America Market Attractiveness by Degree of Burn, 2023 to 2033 Figure 45: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 46: Europe Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 47: Europe Market Value (US$ Million) by Degree of Burn, 2023 to 2033 Figure 48: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 49: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 52: Europe Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 53: Europe Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 54: Europe Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 55: Europe Market Value (US$ Million) Analysis by Degree of Burn, 2018 to 2033 Figure 56: Europe Market Value Share (%) and BPS Analysis by Degree of Burn, 2023 to 2033 Figure 57: Europe Market Y-o-Y Growth (%) Projections by Degree of Burn, 2023 to 2033 Figure 58: Europe Market Attractiveness by Treatment Type, 2023 to 2033 Figure 59: Europe Market Attractiveness by Degree of Burn, 2023 to 2033 Figure 60: Europe Market Attractiveness by Country, 2023 to 2033 Figure 61: South Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 62: South Asia Market Value (US$ Million) by Degree of Burn, 2023 to 2033 Figure 63: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 64: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 65: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 66: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 67: South Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 68: South Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 69: South Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 70: South Asia Market Value (US$ Million) Analysis by Degree of Burn, 2018 to 2033 Figure 71: South Asia Market Value Share (%) and BPS Analysis by Degree of Burn, 2023 to 2033 Figure 72: South Asia Market Y-o-Y Growth (%) Projections by Degree of Burn, 2023 to 2033 Figure 73: South Asia Market Attractiveness by Treatment Type, 2023 to 2033 Figure 74: South Asia Market Attractiveness by Degree of Burn, 2023 to 2033 Figure 75: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 76: East Asia Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 77: East Asia Market Value (US$ Million) by Degree of Burn, 2023 to 2033 Figure 78: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 79: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 80: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 81: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 82: East Asia Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 83: East Asia Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 84: East Asia Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 85: East Asia Market Value (US$ Million) Analysis by Degree of Burn, 2018 to 2033 Figure 86: East Asia Market Value Share (%) and BPS Analysis by Degree of Burn, 2023 to 2033 Figure 87: East Asia Market Y-o-Y Growth (%) Projections by Degree of Burn, 2023 to 2033 Figure 88: East Asia Market Attractiveness by Treatment Type, 2023 to 2033 Figure 89: East Asia Market Attractiveness by Degree of Burn, 2023 to 2033 Figure 90: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 91: Oceania Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 92: Oceania Market Value (US$ Million) by Degree of Burn, 2023 to 2033 Figure 93: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 94: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 95: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 96: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 97: Oceania Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 98: Oceania Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 99: Oceania Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 100: Oceania Market Value (US$ Million) Analysis by Degree of Burn, 2018 to 2033 Figure 101: Oceania Market Value Share (%) and BPS Analysis by Degree of Burn, 2023 to 2033 Figure 102: Oceania Market Y-o-Y Growth (%) Projections by Degree of Burn, 2023 to 2033 Figure 103: Oceania Market Attractiveness by Treatment Type, 2023 to 2033 Figure 104: Oceania Market Attractiveness by Degree of Burn, 2023 to 2033 Figure 105: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 106: MEA Market Value (US$ Million) by Treatment Type, 2023 to 2033 Figure 107: MEA Market Value (US$ Million) by Degree of Burn, 2023 to 2033 Figure 108: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 109: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 110: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 111: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 112: MEA Market Value (US$ Million) Analysis by Treatment Type, 2018 to 2033 Figure 113: MEA Market Value Share (%) and BPS Analysis by Treatment Type, 2023 to 2033 Figure 114: MEA Market Y-o-Y Growth (%) Projections by Treatment Type, 2023 to 2033 Figure 115: MEA Market Value (US$ Million) Analysis by Degree of Burn, 2018 to 2033 Figure 116: MEA Market Value Share (%) and BPS Analysis by Degree of Burn, 2023 to 2033 Figure 117: MEA Market Y-o-Y Growth (%) Projections by Degree of Burn, 2023 to 2033 Figure 118: MEA Market Attractiveness by Treatment Type, 2023 to 2033 Figure 119: MEA Market Attractiveness by Degree of Burn, 2023 to 2033 Figure 120: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports